Connect Biopharma Holdings Ltd (CNTB): Cash & Equivalents
$38.34M
As of 2025-12-31
$27.02M
As of 2026-06-30
| Period ended | Cash & Equivalents | Change YoY | Source filing |
|---|---|---|---|
| 2025-12-31 | $38.34M | -51.0% | 2026-03-31, Balance as of period end |
| 2024-12-31 | $78.23M | -26.0% | 2026-03-31, Balance as of period end |
| 2023-12-31 | $105.66M | n/a | 2025-03-31, Balance as of period end |
Cash & Equivalents at similar companies
| Company | Year ended | Cash & Equivalents | Change YoY |
|---|---|---|---|
| Connect Biopharma Holdings Ltd (CNTB) | 2025-12-31 | $38.34M | -51.0% |
| Inovio Pharmaceuticals, Inc. (INO) | 2025-12-31 | $44.27M | -32.7% |
| Avalo Therapeutics, Inc. (AVTX) | 2025-12-31 | $15.86M | -88.2% |
| Silo Pharma, Inc. (SILO) | 2025-12-31 | $4.75M | +21.6% |
| HCW Biologics Inc. (HCWB) | 2025-12-31 | $1.95M | -58.2% |
| Incannex Healthcare Inc. (IXHL) | 2025-06-30 | $15.04M | +156.7% |
| Actinium Pharmaceuticals, Inc. (ATNM) | 2025-12-31 | $48.00M | -34.2% |
| Altimmune, Inc. (ALT) | 2025-12-31 | $43.76M | +18.5% |
| iBio, Inc. (IBIO) | 2026-06-30 | $56.40M | +557.1% |
Compare CNTB, INO, AVTX, SILO side by side · Screen every company in Pharmaceutical Preparations ↗